H.C. Wainwright lowered the firm’s price target on Evolus (EOLS) to $20 from $27 and keeps a Buy rating on the shares. The company reset its 2025 outlook amid market softness, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EOLS: